Latest News | Shinhan Bank Gets CCI Nod to Acquire 11 Pc Stake in HDFC Credila

Get latest articles and stories on Latest News at LatestLY. The Competition Commission of India (CCI) has cleared South Korea-based Shinhan Bank's proposed acquisition of an 11 per cent stake in HDFC Credila Financial Services.

New Delhi, May 29 (PTI) The Competition Commission of India (CCI) has cleared South Korea-based Shinhan Bank's proposed acquisition of an 11 per cent stake in HDFC Credila Financial Services.

Part of the Shinhan Financial Group, Shinhan Bank Co Ltd is a multinational bank, which commenced operations in India in 1996.

Also Read | Goa Statehood Day 2024 Date: Know History and Significance of Goa Foundation Day Ahead of 37th Anniversary of State’s Formation.

"The proposed combination relates to the acquisition of up to approximately 11 per cent shareholding by Shinhan Bank in HDFC Credila by way of subscription to shares of HDFC Credila," CCI said in a release on Tuesday.

HDFC Credila Financial Services, is a Reserve Bank of India (RBI)-registered non-deposit taking non-banking financial company. It is primarily engaged in the business of providing education loans in India and overseas.

Also Read | Rules Changing From June 1 in India: From New Driving License Rules to Aadhaar Card Update and LPG Cylinder Price Revision, Know List of Changes To Come Into Effect From Next Month.

In another release, the competition watchdog granted its approval to Matrix Pharma to acquire 100 per cent stake in Tianish Laboratories.

The acquisition will be funded in part by an investment proposed to be made by the investors in optionally convertible debentures of Mudhra Labs -- the holding company of Matrix Pharma.

The regulator also cleared investment by Kingsman in compulsorily convertible preference shares of Mudhra Lifesciences, the ultimate holding company of Matrix Pharma.

The proceeds of these investments will be utilised by Matrix Pharma towards the acquisition of Tianish Laboratories.

Tianish Laboratories Pvt Ltd carries out the business of manufacture and sale of active pharmaceutical ingredients in India.

Kingsman Wealth Fund PCC -- Aurisse Special Opportunities Fund (Kingsman) holds a global business license, issued by the Financial Services Commission, Mauritius.

Fair trade regulator CCI said it has cleared the deals.

The deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices as well as promotes fair competition in the marketplace.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now